Overview
Shengpu Zetai provides AI medical service solutions. Combining drug-structure big data with AI, it builds a one-stop AI-CRDMO platform for peptides, peptidomimetics and peptide-drug conjugates (PDC), spanning discovery (CRO) through industrial production (CMO/CDMO). Through joint development with pharmaceutical companies, it provides AI drug molecule design and synthesis, preclinical animal validation, patentable preclinical candidate compounds (PCC), and clinical applications for innovative drugs. It also supplies active pharmaceutical ingredients throughout clinical research and large-scale commercialization after approval.
Connected profiles
Explore
More Health management products
Sources · 0Sources & provenance
English text is maintained separately from the original record. Consult the original source before citing a fact.
No source links are available for this profile.
Original source text
Names may use phonetic renderings when no English name is supplied. The original wording is retained below.
胜普泽泰是一家人工智能医疗服务解决方案提供商，公司将药物结构大数据与人工智能相结合，专注于构建多肽、拟肽以及多肽偶联药物（PDC）从新药发现（CRO）到工业化生产（CMO/CDMO）的一站式AI-CRDMO服务平台。胜普泽泰采用与医药企业共同开发的模式，可为其提供药物分子的AI设计及合成制备、临床前动物实验验证、交付可专利化的临床前候选化合物（PCC）及创新药临床申报等服务，并提供临床研究阶段以及药品上市后大规模商业化全阶段的原料药生产供应。